Morning Movers 02/22: (FONR) (TTHI) (SIGA) (ZRAN) Higher; (DCTH) (DAKT) (AMOT) Lower
FONR Hot Sheet
Revenue Growth %: -100.0%
Fonar Corp. (NASDAQ: FONR) 62.9% HIGHER; reported Q2 EPS of $0.24, versus ($0.26) last year. Revenue for the quarter came in at $8.02 million, versus $8.21 million last year.
Delcath Systems Inc. (Nasdaq: DCTH) 28.9% LOWER; the company received a refusal to file letter from the FDA for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.
Transition Therapeutics (Nasdaq: TTHI) 28.3% HIGHER; shares are surging today as the stock has pushed over a resistance level at $4. The stock has already traded nearly 350,000 shares, which compares to the average daily volume of just 69,000 shares.
Daktronics Inc. (NASDAQ: DAKT) 23.4% LOWER; reported Q3 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $99.9 million versus the consensus estimate of $101 million.
SIGA Technologies, Inc. (Nasdaq: SIGA) 22.1% HIGHER; announced Monday that the Biomedical Advanced Research and Development Authority has advised that it is seeking to acquire 1.7 million courses of a smallpox antiviral.
Allied Motion Technologies Inc. (Nasdaq: AMOT) 19.7% LOWER; reported Q4 adjusted EPS of $0.14, versus $0.04 last year. Revenue for the quarter came in at $21.14 million, versus $17.03 million last year.
Zoran Corp. (Nasdaq: ZRAN) 17.4% HIGHER; agreed to be acquired by CSR plc (OTC: CSRXF) in a deal worth approximately $679 million. Zoran shareholders will receive 1.85 American Depositary Shares of CSR for each share they hold. The stock was also upgraded at Wedbush this morning.
Camtek Ltd. (NASDAQ: CAMT) 15.1% LOWER; reported Q4 adjusted EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $25.4 million versus the consensus estimate of $24 million. Sees flat Q1 revs.
Checkpoint Systems (NYSE: CKP) 12.6% LOWER; reported Q4 EPS of $0.19, which does not compare to the analyst estimate of $0.40. Revenue for the quarter came in at $235.54 million versus the consensus estimate of $238.6 million.
Mentor Graphics (Nasdaq: MENT) 11% HIGHER; activist investor Carl Icahn, in a 13D filing with the SEC, disclosed that he offered to buy the company for $17 per share in cash.
Caraco Pharmaceutical Laboratories, Ltd. (AMEX: CPD) 10% HIGHER; has entered into a merger agreement with Sun Pharmaceutical Industries Limited, Sun Pharma Global, Inc, a wholly-owned subsidiary of Sun Pharma organized under the laws of the British Virgin Islands (Sun Global) and a newly-formed, indirect wholly-owned subsidiary of Sun Pharma incorporated in Michigan. Under the agreement, Caraco shareholders will receive $5.25 per share in cash.
NxStage Medical, Inc. (Nasdaq: NXTM) 9.2% LOWER; releases the following interim results from its ongoing FREEDOM study which show an increase in overall quality of life benefits, significant improvement in overall sleep quality and a marked improvement in Restless Legs Syndrome symptoms experienced by patients after 12 months of daily home hemodialysis with the NxStage System One.
Barnes & Noble, Inc. (NYSE: BKS) 8.8% LOWER; reported Q3 EPS of $1.00, $0.13 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.38 billion. Suspending its dividend.
Clinical Data, Inc. (NASDAQ: CLDA) 8.7% LOWER; Forest Laboratories, Inc. (NYSE: FRX) and Clinical Data today announced that they have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid upon achievement of certain commercial milestones related to Viibryd™.
Sina Corp. (Nasdaq: SINA) 8.7% LOWER; Deutsche Bank downgraded SINA Corporation from Hold to Sell. PT $58.
To get this report daily, goto http://www.streetinsider.com/entities/Morning+Movers.
Delcath Systems Inc. (Nasdaq: DCTH) 28.9% LOWER; the company received a refusal to file letter from the FDA for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.
Transition Therapeutics (Nasdaq: TTHI) 28.3% HIGHER; shares are surging today as the stock has pushed over a resistance level at $4. The stock has already traded nearly 350,000 shares, which compares to the average daily volume of just 69,000 shares.
Daktronics Inc. (NASDAQ: DAKT) 23.4% LOWER; reported Q3 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $99.9 million versus the consensus estimate of $101 million.
SIGA Technologies, Inc. (Nasdaq: SIGA) 22.1% HIGHER; announced Monday that the Biomedical Advanced Research and Development Authority has advised that it is seeking to acquire 1.7 million courses of a smallpox antiviral.
Allied Motion Technologies Inc. (Nasdaq: AMOT) 19.7% LOWER; reported Q4 adjusted EPS of $0.14, versus $0.04 last year. Revenue for the quarter came in at $21.14 million, versus $17.03 million last year.
Zoran Corp. (Nasdaq: ZRAN) 17.4% HIGHER; agreed to be acquired by CSR plc (OTC: CSRXF) in a deal worth approximately $679 million. Zoran shareholders will receive 1.85 American Depositary Shares of CSR for each share they hold. The stock was also upgraded at Wedbush this morning.
Camtek Ltd. (NASDAQ: CAMT) 15.1% LOWER; reported Q4 adjusted EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $25.4 million versus the consensus estimate of $24 million. Sees flat Q1 revs.
Checkpoint Systems (NYSE: CKP) 12.6% LOWER; reported Q4 EPS of $0.19, which does not compare to the analyst estimate of $0.40. Revenue for the quarter came in at $235.54 million versus the consensus estimate of $238.6 million.
Mentor Graphics (Nasdaq: MENT) 11% HIGHER; activist investor Carl Icahn, in a 13D filing with the SEC, disclosed that he offered to buy the company for $17 per share in cash.
Caraco Pharmaceutical Laboratories, Ltd. (AMEX: CPD) 10% HIGHER; has entered into a merger agreement with Sun Pharmaceutical Industries Limited, Sun Pharma Global, Inc, a wholly-owned subsidiary of Sun Pharma organized under the laws of the British Virgin Islands (Sun Global) and a newly-formed, indirect wholly-owned subsidiary of Sun Pharma incorporated in Michigan. Under the agreement, Caraco shareholders will receive $5.25 per share in cash.
NxStage Medical, Inc. (Nasdaq: NXTM) 9.2% LOWER; releases the following interim results from its ongoing FREEDOM study which show an increase in overall quality of life benefits, significant improvement in overall sleep quality and a marked improvement in Restless Legs Syndrome symptoms experienced by patients after 12 months of daily home hemodialysis with the NxStage System One.
Barnes & Noble, Inc. (NYSE: BKS) 8.8% LOWER; reported Q3 EPS of $1.00, $0.13 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.38 billion. Suspending its dividend.
Clinical Data, Inc. (NASDAQ: CLDA) 8.7% LOWER; Forest Laboratories, Inc. (NYSE: FRX) and Clinical Data today announced that they have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid upon achievement of certain commercial milestones related to Viibryd™.
Sina Corp. (Nasdaq: SINA) 8.7% LOWER; Deutsche Bank downgraded SINA Corporation from Hold to Sell. PT $58.
To get this report daily, goto http://www.streetinsider.com/entities/Morning+Movers.
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Carl Icahn, Deutsche Bank, Dividend, Morning Movers, 13DSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
